PV QA 1 - Poster Viewing Q&A 1
SU_45_2454 - miR-125a-5p Functions as a Tumor Suppressor MicroRNA By Regulating Cell Proliferation and Radioresistance and Is a Marker of Poor Prognosis in Head and Neck Cancer
Sunday, October 21
1:15 PM - 2:45 PM
Location: Innovation Hub, Exhibit Hall 3
miR-125a-5p Functions as a Tumor Suppressor MicroRNA By Regulating Cell Proliferation and Radioresistance and Is a Marker of Poor Prognosis in Head and Neck Cancer
D. T. Vo1, N. K. Karanam2, L. Ding3, D. Saha3, and M. D. Story3; 1Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, 2UT Southwestern Medical Center, Dallas, TX, 3University of Texas Southwestern Medical Center, Dallas, TX
Purpose/Objective(s): MicroRNAs (miRNAs) are small single-stranded RNAs, measuring approximately 22 nucleotides in length and regulate gene expression at the post-transcriptional level through mRNA destabilization or repressing protein synthesis. Dysregulation of microRNAs can lead to tumorigenesis through changes in regulation of key cellular processes such as cell proliferation, cell survival, and apoptosis. miR-125a-5p has been implicated as a tumor suppressor miRNA in malignancies such as non-small cell lung cancer and colon cancer. However, the role of miR-125a-5p has not been fully investigated in head and neck squamous cell carcinoma (HNSCC).
Materials/Methods: We utilized a panel of tumor samples from patients with high risk HNSCC to identify an association between miR-125a-5p expression and disease recurrence followed by utilizing The Cancer Genome Atlas to investigate the association between low expression of miR-125a-5p and survival. We then performed cell proliferation assays as well as flow cytometric analysis of cell cycle using the HN5 and UM-SCC-22B cell lines. An in vitro scratch assay was used to assay for cell migration. Clonogenic assays were utilized to interrogate sensitivity of miR-125a-5p to ionizing radiation. Finally, putative targets of miR-125a-5p will be predicted using a combination of in silico methods, combining gene expression analysis and miRNA binding site conservation.
Results: miR-125a-5p downregulation was associated with recurrent disease in a panel of high risk HNSCC and then confirmed poor survival associated with low expression in HNSCC via The Cancer Genome Atlas, suggesting that miR-125a-5p acts as a tumor suppressor miRNA. We then demonstrated that miR-125a-5p regulates cell proliferation through cell cycle regulation at the G1/S transition. We also show that miR-125a-5p can alter cell migration and modulate sensitivity to ionizing radiation. Finally, we identified putative mRNA targets of miR-125a-5p, including ERBB2, EIF4EBP1, and TXNRD1, which support the tumor suppressive mechanism of miR-125a-5p.
Conclusion: In sum, our data suggests that miR-125a-5p acts as a tumor suppressor miRNA, has potential as a diagnostic tool and may be a potential therapeutic target for the management and treatment of squamous cell carcinoma of the head and neck.
Author Disclosure: D.T. Vo: None. N.K. Karanam: None. M.D. Story: Research Grant; Galera Therapeutics LLC. Grant, honoraria for speaking, honoraria for meeting organization; Novocure. Honoraria; Novocure. Travel Expenses; Galera Therapeutics LLC.